Figure 2.
Figure 2. Distribution of individual organ severity scores of cGVHD within global severity mild-moderate-severe staging categories. Data were obtained from the prospective study of the US cGVHD consortium (N = 298). The severity score accounts for both the magnitude of clinical manifestations and the degree of functional impairment. Reprinted with permission from Arai et al.19

Distribution of individual organ severity scores of cGVHD within global severity mild-moderate-severe staging categories. Data were obtained from the prospective study of the US cGVHD consortium (N = 298). The severity score accounts for both the magnitude of clinical manifestations and the degree of functional impairment. Reprinted with permission from Arai et al.19 

Close Modal

or Create an Account

Close Modal
Close Modal